HudgelDWWeilJV: Depression of hypoxic and hypercapnic ventilatory drives in severe asthma. Chest1975; 4: 493–497.
2.
KikuchiYOkabeSTamuraGHidaWHommaMShiratoK: Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med1994; 330: 1329–1334.
3.
ZwillichCWPiersonDJHofeldtFDLufkinEGWeilJV: Ventilatory control in myxedema and hypothyroidism. N Engl J Med1975; 292: 662–665.
4.
KawakamiYIrieTShidaAYoshikawaT: Familial factors affecting arterial blood gas values and respiratory chemosensitivity in chronic obstructive pulmonary disease. Am Rev Respir Dis1982; 125: 420–425.
5.
PetersonDDPackAISilageDAFishmanAP: Effects of aging on ventilatory and occlusion pressure responses to hypoxia and hyper-capnia. Am Rev Respir Dis1981; 124: 387–391.
6.
PokorskiMMarczakM: Ventilatory response to hypoxia in elderly women. Ann Hum Biol2003; 30: 53–64.
7.
LevitzkyMG: Effects of aging on the respiratory system. Physiologist1984; 27: 102–107.
8.
WolinMSBurke-WolinTMMohazzab-HKM: Roles for NAD(P)H oxidases and reactive oxygen species in vascular oxygen sensing mechanisms. Respir Physiol1999; 115: 229–238.
9.
GonzalezCVicarioIAlmarazLRigualR: Oxygen sensing in the carotid body. Biol Signals1995; 4: 245–256.
10.
WeirEKArcherSL: The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels. FASEB J1995; 9: 183–189.
11.
WaypaGBChandelNSSchumackerPT: Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res2001; 88: 1259–1266.
12.
PokorskiMGonetB: Hypoxia depletes ascorbate in the cat carotid body. Respir Physiol1997; 107: 213–218.
13.
MuzaSRSilvermanMTGilmoreGCHellersteinHKKelsenSG: Comparison of scales used to quantitate the sense of effort to breathe in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis1990; 141: 909–913.
14.
MedinaARde CórdovaML FernándezDiazAM: A rapid and selective solid-phase UV spectrophotometric method for determination of ascorbic acid in pharmaceutical preparations and urine. J Pharm Biomed Anal1999; 20: 247–254.
15.
PokorskiMMarczakM: Vitamin C in respiratory impairment revisited. In: 3rd Mediterranean Congress on Thoracic Diseases (AntypasG, ed). Bologna, Italy: Monduzzi Editore-Medimond Inc., 2000; pp53–60.
16.
KelmanGRWatsonAW: Effect of respiratory dead-space on the Hey plot. J Physiol1972; 227: 47P–49P.
17.
RoebothanBVChandraRK: Relationship between nutritional status and immune function of elderly people. Age Ageing1994; 23: 49–53.
18.
MilneJSLonerganMEWilliamsonJMooreFMMcMasterRPercyN: Leucocyte ascorbic acid levels and vitamin C intake in older people. BMJ1971; 4: 383–386.
19.
van KlaverenRJDemedtsM: Determinants of the hypercapnic and hypoxic response in normal men. Respir Physiol1998; 113: 157–165.
20.
TeppemaLJNieuwenhuijsDSartonERombergROlievierCNWardDS: Antioxidants prevent depression of the acute hypoxic ventilatory response by subanaesthetic halothane in men. J Physiol2002; 544: 931–938.
21.
KnillRLClementJL: Site of selective action of halothane on the peripheral chemoreflex pathway in humans. Anesthesiology1984; 61: 121–126.
22.
Perez-GarciaMTLopez-LopezJR: Are Kv channels the essence of O2 sensing?Circ Res2000; 86: 490–491.
23.
DuchenMRBiscoeTJ: Mitochondrial function in type I cells isolated from rabbit arterial chemoreceptors. J Physiol1992; 450: 13–31.
24.
SjöstrandSE: Pharmacological properties of dehydroascorbic acid and ascorbic acid. Effects on the central and peripheral nervous systems in experimental animals. Acta Physiol Scand Suppl1970; 356: 5–74.
25.
GautierHRemmersJEBartlettDJr: Control of the duration of respiration. Respir Physiol1973; 18: 205–221.
26.
MoritaKLevineMPollardHB: Stimulatory effect of ascorbic acid on norepinephrine biosynthesis in digitonin-permeabilized adrenal medullary chromaffin cells. J Neurochem1986; 46: 939–945.
27.
LahiriSPokorskiMDaviesRO: Augmentation of carotid body chemoreceptor responses by isoproterenol in the cat. Respir Physiol1981; 44: 351–364.
28.
KallnerAHornigDPellikkaR: Formation of carbon dioxide from ascorbate in man. Am J Clin Nutr1985; 41: 609–613.
29.
De RitterECohenNRubinSH: Physiological availability of dehydro-L-ascorbic acid and palmitoyl-L-ascorbic acid. Science1951; 113: 628–630.
30.
LevineMDhariwalKRWelchRWWangYParkJB: Determination of optimal vitamin C requirements in humans. Am J Clin Nutr1995; 62 (6 Suppl): 1347S–1356S.
31.
HorningD: Distribution of ascorbic acid, metabolites and analogues in man and animals. Ann N Y Acad Sci1978; 258: 103–118.